These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 15637602)

  • 1. Kiran Mazumdar-Shaw.
    Jayaraman KS
    Nat Biotechnol; 2005 Jan; 23(1):11. PubMed ID: 15637602
    [No Abstract]   [Full Text] [Related]  

  • 2. Growing against the grain.
    Boyle M
    Fortune; 2004 May; 149(9):148-9, 152, 154 passim. PubMed ID: 15124331
    [No Abstract]   [Full Text] [Related]  

  • 3. Taiwan: Biotech vision.
    Cyranoski D
    Nat Biotechnol; 2003 Apr; 21(4):463-4. PubMed ID: 12665831
    [No Abstract]   [Full Text] [Related]  

  • 4. An embargoed Cuban science.
    Smith C
    Genet Anal; 1999 Nov; 15(3-5):71-2. PubMed ID: 10596742
    [No Abstract]   [Full Text] [Related]  

  • 5. Kiran Mazumdar-Shaw.
    Mazumdar-Shaw K
    Nat Rev Drug Discov; 2010 Jul; 9(7):510. PubMed ID: 20592739
    [No Abstract]   [Full Text] [Related]  

  • 6. Real options for biotechnology valuation.
    Harrison M; Lerer L
    Nat Biotechnol; 2002 Mar; 20(3):223-4. PubMed ID: 11875412
    [No Abstract]   [Full Text] [Related]  

  • 7. A time for growth: an interview with Amgen CEO Kevin Sharer. Interview by Paul Hemp.
    Sharer K
    Harv Bus Rev; 2004; 82(7-8):66-74, 186. PubMed ID: 15241953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Start-ups weigh benefits of corporate incubators.
    Waltz E
    Nat Biotechnol; 2008 Mar; 26(3):254-5. PubMed ID: 18327219
    [No Abstract]   [Full Text] [Related]  

  • 9. Micro moulding: the route to a successful product.
    Whiteside B; Manser P
    Med Device Technol; 2009; 20(2):18, 20-1. PubMed ID: 19405338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investors bullish in Q1.
    Lawrence S
    Nat Biotechnol; 2006 May; 24(5):486. PubMed ID: 16680118
    [No Abstract]   [Full Text] [Related]  

  • 11. The number on biotech indexes.
    Jacobs T
    Nat Biotechnol; 2005 Nov; 23(11):1356. PubMed ID: 16273059
    [No Abstract]   [Full Text] [Related]  

  • 12. Finnish biotechnology--built on solid foundations.
    Lähteenmäki R
    Nature; 2002 Dec; 420(6916 Suppl):A34-5, A37, A39. PubMed ID: 12501125
    [No Abstract]   [Full Text] [Related]  

  • 13. On the road to California.
    DeWitt N
    Nature; 2002 Dec; 420(6916 Suppl):A9. PubMed ID: 12510695
    [No Abstract]   [Full Text] [Related]  

  • 14. The biotechnology industry: What's next?
    Guertin PA
    Biotechnol J; 2009 Aug; 4(8):1124-31. PubMed ID: 19685466
    [No Abstract]   [Full Text] [Related]  

  • 15. Biotech's new colossus. Move over, Big Pharma. Amgen boasts better growth.
    Stipp D
    Fortune; 2002 Apr; 145(8):144-6, 148, 150. PubMed ID: 11961884
    [No Abstract]   [Full Text] [Related]  

  • 16. Genzyme and Isis strike megadeal.
    Mack GS
    Nat Biotechnol; 2008 Mar; 26(3):251-3. PubMed ID: 18327216
    [No Abstract]   [Full Text] [Related]  

  • 17. France critiques its incubator before refinancing.
    Louët S
    Nat Biotechnol; 2004 Jan; 22(1):126. PubMed ID: 14725299
    [No Abstract]   [Full Text] [Related]  

  • 18. New pharma-biotech company formation in India.
    Saberwal G
    Nat Biotechnol; 2006 May; 24(5):499-501. PubMed ID: 16680124
    [No Abstract]   [Full Text] [Related]  

  • 19. At ground level.
    Bertschinger J
    Nat Biotechnol; 2010 Aug; 28(8):775-7. PubMed ID: 20722095
    [No Abstract]   [Full Text] [Related]  

  • 20. IPO floodgates unlikely to open after Ark floatation.
    Louët S
    Nat Biotechnol; 2004 Apr; 22(4):367-8. PubMed ID: 15060538
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.